文献速递胸部CT

胸部X线等效超低剂量CT的肺气肿定量与肺容积测定——与标准剂量CT的个体内比较

Emphysema quantification and lung volumetry in chest X-ray equivalent ultralow dose CT - Intra-individual comparison with standard dose CT.
PubMed 文献 · Eur J Radiol · 2017-03-14

前瞻性单中心研究纳入84例连续患者,同次扫描行标准剂量CT(1.7±0.6mSv)与超低剂量CT(0.14±0.01mSv,100kV、70mAs、锡滤过)。超低剂量CT联合ADMIRE重建可检测和定量肺气肿并测量肺容积;但纵向肺气肿分析应使用相同扫描方案和重建算法。

要点

  • 超低剂量CT(0.14±0.01mSv)联合ADMIRE重建可用于肺气肿检测、定量及肺容积测定。
  • 标准剂量FBP与超低剂量ADMIRE 4的LAA无统计学显著差异(p=0.358)。
  • 纵向肺气肿分析应使用相同扫描方案和重建算法以保证可重复性。

核心结论

  • 胸部X线等效剂量的超低剂量CT可进行肺容积测定以及肺气肿的检测和定量,但纵向肺气肿分析应使用相同扫描方案和重建算法以保证可重复性。

研究设计与样本

  • 前瞻性、经IRB批准的单中心研究,连续纳入84例患者,同次扫描行临床指征标准剂量胸部CT(1.7±0.6mSv)及追加单能超低剂量CT(0.14±0.01mSv,100kV、固定管电流70mAs、锡滤过)。84例中40例(48%)无肺气肿,44例(52%)有肺气肿。由一名放射科医师用全自动软件对标准剂量和超低剂量CT不同ADMIRE级别行肺气肿定量和肺容积测定。统计学采用Friedman检验和Wilcoxon秩和检验进行多重比较,肺容积用一致性相关系数比较。

关键影像表现/征象

  • 标准剂量FBP重建的中位低衰减区(LAA)为4.4%,ADMIRE 3、4、5分别降至2.6%、2.1%和1.8%。
  • 超低剂量CT的LAA中位数在ADMIRE 3、4、5分别为5.7%、4.1%和2.4%。
  • 标准剂量FBP与超低剂量ADMIRE 4的LAA无统计学显著差异(p=0.358);标准剂量ADMIRE 3与超低剂量ADMIRE 5的LAA亦无统计学显著差异(p=0.966)。
  • 与标准剂量FBP相比,肺容积一致性相关系数在标准剂量ADMIRE 3、4、5分别为1.000、0.999和0.999,在超低剂量CT ADMIRE 3、4、5为0.972。

诊断标准与关键数值

  • 以低衰减区(LAA)百分比进行肺气肿定量,比较标准剂量与超低剂量CT在不同ADMIRE重建级别下的LAA中位数。
  • 标准剂量FBP与超低剂量ADMIRE 4的LAA差异无统计学显著意义(p=0.358)。
  • 标准剂量ADMIRE 3与超低剂量ADMIRE 5的LAA差异无统计学显著意义(p=0.966)。
  • 与标准剂量FBP相比,超低剂量CT肺容积的一致性相关系数为0.972。

临床应用与阅片要点

  • 超低剂量CT联合ADMIRE重建可用于肺气肿检测、定量及肺容积测定。
  • 纵向肺气肿分析应使用相同扫描方案和重建算法以保证可重复性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine whether ultralow dose chest CT with tin filtration can be used for emphysema quantification and lung volumetry and to assess differences in emphysema measurements and lung volume between standard dose and ultralow dose CT scans using advanced modeled iterative reconstruction (ADMIRE).

METHODS: 84 consecutive patients from a prospective, IRB-approved single-center study were included and underwent clinically indicated standard dose chest CT (1.7±0.6mSv) and additional single-energy ultralow dose CT (0.14±0.01mSv) at 100kV and fixed tube current at 70mAs with tin filtration in the same session. Forty of the 84 patients (48%) had no emphysema, 44 (52%) had emphysema. One radiologist performed fully automated software-based pulmonary emphysema quantification and lung volumetry of standard and ultralow dose CT with different levels of ADMIRE. Friedman test and Wilcoxon rank sum test were used for multiple comparison of emphysema and lung volume. Lung volumes were compared using the concordance correlation coefficient.

RESULTS: The median low-attenuation areas (LAA) using filtered back projection (FBP) in standard dose was 4.4% and decreased to 2.6%, 2.1% and 1.8% using ADMIRE 3, 4, and 5, respectively. The median values of LAA in ultralow dose CT were 5.7%, 4.1% and 2.4% for ADMIRE 3, 4, and 5, respectively. There was no statistically significant difference between LAA in standard dose CT using FBP and ultralow dose using ADMIRE 4 (p=0.358) as well as in standard dose CT using ADMIRE 3 and ultralow dose using ADMIRE 5 (p=0.966). In comparison with standard dose FBP the concordance correlation coefficients of lung volumetry were 1.000, 0.999, and 0.999 for ADMIRE 3, 4, and 5 in standard dose, and 0.972 for ADMIRE 3, 4 and 5 in ultralow dose CT.

CONCLUSIONS: Ultralow dose CT at chest X-ray equivalent dose levels allows for lung volumetry as well as detection and quantification of emphysema. However, longitudinal emphysema analyses should be performed with the same scan protocol and reconstruction algorithms for reproducibility.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Messerli M, Ottilinger T, Warschkow R, et al. Emphysema quantification and lung volumetry in chest X-ray equivalent ultralow dose CT - Intra-individual comparison with standard dose CT. Eur J Radiol. 2017. PMID: 28629554. doi:10.1016/j.ejrad.2017.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。